Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

PCN Insights, News, Videos, and More

Pills spill out of an orange prescription bottle.
News
01/09/2024
Brionna Mendoza
Clinicians now have a new treatment option available for pediatric attention-deficit/hyperactivity disorder (ADHD): methylphenidate hydrochloride extended-release tablets (Relexxii).
Clinicians now have a new treatment option available for pediatric attention-deficit/hyperactivity disorder (ADHD): methylphenidate hydrochloride extended-release tablets (Relexxii).
Clinicians now have a new...
01/09/2024
Psych Congress Network
Desiree Matthews, PHMNP-BC
Videos
01/09/2024

With Desiree Matthews, PHMNP-BC

With Desiree Matthews, PHMNP-BC ...
Desiree Matthews, PHMNP-BC, discusses how to better screen for bipolar disorder and her tips for clinicians working with this patient population.
Desiree Matthews, PHMNP-BC, discusses how to better screen for bipolar disorder and her tips for clinicians working with this patient population.
Desiree Matthews, PHMNP-BC,...
01/09/2024
Psych Congress Network
a doctor and patient sit on couches talking
News
01/05/2024
Brionna Mendoza
Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.
Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.
Atypical long-acting injectable...
01/05/2024
Psych Congress Network
News
01/05/2024
Tom Valentino, Digital Managing Editor
The temporary codes, which went into effect this week, allow providers to seek coverage and reimbursement for delivery of psychedelic-assisted therapies, pending their approval by the FDA.
The temporary codes, which went into effect this week, allow providers to seek coverage and reimbursement for delivery of psychedelic-assisted therapies, pending their approval by the FDA.
The temporary codes, which went...
01/05/2024
Psych Congress Network
Rakesh Jain at Psych Congress Regionals
News
01/04/2024
Meagan Thistle
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered...
01/04/2024
Psych Congress Network
Brain with puzzle piece missing
News
01/03/2024
Jolynn Tumolo
Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.
Daily vitamin B6 as adjunctive therapy to lithium was associated with the improvement of mood symptoms in hospitalized patients with bipolar disorder experiencing a manic episode.
Daily vitamin B6 as adjunctive...
01/03/2024
Psych Congress Network
Oral Contraceptive Use Associated With Reduced Depression Risk
News
01/03/2024
Evi Arthur
Current users of oral contraceptive pills (OCPs) may have more of a reduced risk of major depression than those who formerly or have never used OCPs, according to a recent cross-sectional study published in the Journal of Affective Disorders. 
Current users of oral contraceptive pills (OCPs) may have more of a reduced risk of major depression than those who formerly or have never used OCPs, according to a recent cross-sectional study published in the Journal of Affective Disorders. 
Current users of oral...
01/03/2024
Psych Congress Network
Long-term ADHD Med Use May Hike CVD Risk
News
01/02/2024
Evi Arthur
Long-term exposure to medications for attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of cardiovascular disease (CVD) in a case-control study published in JAMA Psychiatry. 
Long-term exposure to medications for attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of cardiovascular disease (CVD) in a case-control study published in JAMA Psychiatry. 
Long-term exposure to...
01/02/2024
Psych Congress Network
Dr Julie Carbray
Videos
12/28/2023

With Julie Carbray, PhD, PMHNP-BC

With Julie Carbray, PhD, PMHNP-BC ...
In this video interview filmed at the Psych Congress NP Institute 2023, Julie Carbray, PhD, examines how to discuss medication choices with patients and effective communication.
In this video interview filmed at the Psych Congress NP Institute 2023, Julie Carbray, PhD, examines how to discuss medication choices with patients and effective communication.
In this video interview filmed...
12/28/2023
Psych Congress Network
News
12/28/2023
Jolynn Tumolo
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of obsessive-compulsive behaviors and perseverative behaviors in patients with Huntington disease is uncommon and may allow clinically important behaviors to go unnoticed, according to a review article published in...
Separate reporting of...
12/28/2023
Neurology

Advertisement

Advertisement

Advertisement

Advertisement